Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Celera Presents Data Replicating Its Immunodiagnostic Assay To Detect Lung Cancer From Blood Serum
Celera Corporation (NASDAQ:CRA) announced yesterday the presentation of data replicating its novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer (NSCLC) in an independent cohort of individuals with lung cancer. This study was performed in collaboration with scientists at NYU Langone Medical Center, NY. A key outcome of the study was the validation of a 9 biomarker immunoassay on a cohort of samples that is enriched for stage I disease, important for screening of early stage disease. The assay detected lung cancer with 92% sensitivity at 93% specificity. The panel also accurately distinguished malignant cases from benign lung disease. The data is being presented at the 13th World Conference on Lung Cancer as part of the International Association for the Study of Lung Cancer (IASLC) in San Francisco, CA. Don't forget to buy zoloft online no prescription.

Global Fund Faces $3B Funding Shortfall
The Global Fund to Fight AIDS, Tuberculosis and Malaria is facing a budget shortfall of about $3 billion, Marcela Rojo, a Global Fund spokesperson, said on Friday, Reuters reports. Rojo said the Global Fund needs $170 million to pay for the programs it committed to supporting last year, and the organization will need between $2.5 billion and $3 billion to maintain and finance programs planned for 2010. "The Global Fund will need a substantially higher amount than the one pledged at the last replenishment in Berlin in 2007 ($10 billion)," Rojo said, adding, "The decisions that are made in the next 18 months will be critical for sustaining the gains achieved in global health so far and further scaling up programmes."

generic viagra online


News of the day
SAMe Is Effective In Preventing Formation Of Primary Liver Cancer In Rats
A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats. However, high enough levels of SAMe were not attainable to successfully treat established HCC. The findings are available in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases.
Endocrinology

Royal Society Awards Recognise MRC Scientists

Four members of the Medical Research Council community were recognised for their contribution to science by the Royal Society. Professor Ronald Laskey has been awarded one of the Royal Society"s 2009 Royal Medals for his pivotal contributions to our understanding of the control of DNA replication and nuclear protein transport, which has led to a novel screening method for cancer diagnosis. Prof Laskey, joint director of the MRC Cancer Cell Unit and vice-president of the Academy of Medical Sciences, has also previously been awarded the Louis Jeantet Prize for Medicine, the Medical Futures Cancer Innovation Award and the Tomorrow"s World award for Health Innovation. On the receipt of his award Professor Laskey said, "It feels both flattering and humbling to see the list of past recipients but it is particularly pleasing to receive this level of recognition from your peers. "I am particularly grateful to the past and present members of my research team, whose efforts have made this recognition possible." Professor Ashok Venkitaraman, Joint Director of the MRC Cancer Cell Unit with Professor Laskey, said: "Ron Laskey"s work over the years has provided a foundation for many topical and important fields in biomedical research, ranging from nuclear transfer and embryo cloning, to mammalian DNA replication. "The way in which he has translated his fundamental research on DNA replication to the development of important new tools for the early diagnosis of human cancers is a lesson in how biological knowledge can be used to benefit human health. He has mentored and nurtured the careers of many younger colleagues. I am delighted that Ron"s outstanding contributions to the biomedical sciences have been recognised by the Royal Society." Also recognised by the Royal Society today is Sir Martin Evans, who receives the Royal Society"s Copley medal for his seminal work on embryonic stem cells in mice, which revolutionised the field of genetics. Sir Martin, an MRC-funded scientist and Nobel prize winner, is Director of the School of Biosciences and Professor of Mammalian Genetics at Cardiff University. Dr Jason Chin, from the Division of Protein and Nucleic Acid Chemistry at the MRC Laboratory of Molecular Biology, has been chosen to present the annual Francis Crick Lecture for the Royal Society in November. Former MRC chief executive Professor Colin Blakemore will deliver the Ferrier Lecture at the Society next year. The Royal Society, the UK"s independent academy for science, awards in recognition of their achievements in a wide variety of fields of research - the uniting factor is the excellence of their work and the profound implications their findings have had for others working in their relevant fields. Three Royal Medals are awarded annually for the most important contributions to the advancement of natural knowledge and for distinguished contributions in interdisciplinary or applied sciences. The Royal Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009